We are Sorry, This Page doesn't Exist
Myovant Sciences drops after FDA places partial clinical hold on Phase 3 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Athenex announces presentation of clinical data from GINAKIT2 phase 1 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Cue Biopharma announces interim clinical data on phase 1 study of CUE-101
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Panbela reports partial clinical hold lifted on Phase 1 study of SBP-101
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Mustang Bio announces removal of clinical hold for Phase 2 MB-107 trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
BeyondSpring Reports Fourth-Quarter and Full-Year 2019 Financial Results and Operational Update
- FDA Submission to Change the Primary Endpoint for Study 106 Phase 3 into an Industry First and Robust Clinical Measure to Evaluate Superiority in CIN - - Initiated NDA Rolling Submission for Plinabulin for CIN in China in Q1 2020 - - On Track.....»»
Recce Pharmaceuticals Announces First-Quarter 2020 Financial Results and Provides Operational Highlights
Highlights: Strong cash position with reserves of AUD $4.09M Formalized a Phase I Clinical trial agreement to conduct a first-in-human study of RECCE® 327 Completed successful in-vivo toxicity st.....»»
Verastem announces preliminary data from VS-6766 Phase 1 clinical study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Immunovant announces clinical results from ongoing Phase 2a study of IMVT-1401
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Biogen announces enrollment completion of Phase 3 STAR clinical study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Athenex announces initiation of Phase 1 clinical study of KX2-361 in China
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
FibroGen announces first patient dosed in ZEPHYRUS Phase 3 clinical study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Unum Therapeutics announces clinical hold on Phase 1 ATTCK-20-2 trial from FDA
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Akero announces dosing of first patient in Phase 2a clinical study of AKR-001
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AbbVie: FDA lifts partial clinical hold on Phase 3 study of venetoclax
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Celgene announces updated analysis of data from Phase 2 JAKARTA2 clinical study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
BrainStorm announces second clinical site to enroll patients in MS Phase 2 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Advaxis says FDA lifts partial clinical hold on Phase 3 AIM2CERV study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Xencor says FDA lifts partial clinical hold on Phase 1 study of XmAb14045
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Precigen announces first patient dosed in Phase 1 clinical study of INXN-4001
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»